These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 11462017)

  • 21. Transfer of endogenous retroviral superantigen from donor to recipient B cells following priming to induce peripheral T cell tolerance.
    Modlin CS; Todd GT; Cohen TD; Fairchild RL
    Cell Immunol; 1995 Sep; 164(2):217-26. PubMed ID: 7656330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and presentation of endogenous mouse mammary tumor virus superantigens by thymic and splenic dendritic cells and B cells.
    Ardavín C; Waanders G; Ferrero I; Anjuère F; Acha-Orbea H; MacDonald HR
    J Immunol; 1996 Oct; 157(7):2789-94. PubMed ID: 8816381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MHC-specific recognition of a bacterial superantigen by weakly reactive T cells.
    Surman S; Deckhut AM; Blackman MA; Woodland DL
    J Immunol; 1994 May; 152(10):4893-902. PubMed ID: 8176210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A maternally inherited superantigen encoded by a mammary tumour virus.
    Marrack P; Kushnir E; Kappler J
    Nature; 1991 Feb; 349(6309):524-6. PubMed ID: 1846947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A maternally-inherited alteration in the T cell repertoire of BALB/c mice.
    Goldman A; Buggiano V; Franco M; Déroche A; Nepomnaschy I; Piazzon I
    Medicina (B Aires); 1995; 55(1):45-7. PubMed ID: 7565035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maternal transfer of infectious mouse mammary tumor retroviruses does not depend on clonal deletion of superantigen-reactive V beta 14+ T cells.
    Penninger JM; Wallace VA; Timms E; Mak TW
    Eur J Immunol; 1994 May; 24(5):1102-8. PubMed ID: 8181521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of superantigen recognition by peptides of the variable region of the T cell receptor beta chain.
    MacNeil D; Fraga E; Singh B
    Eur J Immunol; 1992 Apr; 22(4):937-41. PubMed ID: 1532364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of Mtv-7 sag gene in vivo using a retroviral vector results in selective inactivation of superantigen reactive T cells.
    Kang J; Ido E; Pawling J; Beutner U; Huber BT; Hozumi N
    J Immunol; 1994 Feb; 152(3):1039-46. PubMed ID: 8301116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dramatic hyperplasia of mtv-2+ lymph node grafts in mtv-2- recipients and selective stimulation of V beta 14+ T cells in recipients' lymph nodes in the DDD mouse.
    Matsuzawa A; Nakano H; Sakamoto S; Yoshimoto T; Nariuchi H
    J Immunol; 1995 Feb; 154(4):1644-52. PubMed ID: 7836749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo T cell response to viral superantigen. Selective migration rather than proliferation.
    Le Bon A; Lucas B; Vasseur F; Penit C; Papiernik M
    J Immunol; 1996 Jun; 156(12):4602-8. PubMed ID: 8648102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistence of V beta 6+ T cells in Mls-1a mice. A role for the third complementarity-determining region (CDR3) of the T cell receptor beta chain in superantigen recognition.
    Chies JA; Marodon G; Joret AM; Regnault A; Lembezat MP; Rocha B; Freitas AA
    J Immunol; 1995 Nov; 155(9):4171-8. PubMed ID: 7594572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of MMTV superantigen presentation in MHC class II-deficient mice.
    Beutner U; McLellan B; Kraus E; Huber BT
    Cell Immunol; 1996 Mar; 168(2):141-7. PubMed ID: 8640859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonspecific augmentation of lymph node T cells and I-E-independent selective deletion of V beta 14+ T cells by Mtv-2 in the DDD mouse.
    Nakano H; Yoshimoto T; Kakiuchi T; Matsuzawa A
    Eur J Immunol; 1993 Oct; 23(10):2434-9. PubMed ID: 8405042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Junctional diversity prevents negative selection of an antigen-specific T cell repertoire.
    Kilgannon P; Novak Z; Fotedar A; Singh B
    Mol Immunol; 2010 Feb; 47(5):1154-60. PubMed ID: 19954850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of CD28 costimulation in immune-mediated responses against mouse mammary tumor viruses.
    Palmer LD; Saha B; Hodes RJ; Abe R
    J Immunol; 1996 Mar; 156(6):2112-8. PubMed ID: 8690899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The J alpha segment contributes to the affinity of V beta 6+ cells for vSAG-7 (Mls-1a) presented by I-A molecules.
    Churaqui E; Oukka M; Tilloy F; Mayadoux E; Bruley-Rosset M; Kosmatopoulos K
    Immunology; 1995 Apr; 84(4):609-18. PubMed ID: 7790035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
    Golovkina TV; Dudley JP; Ross SR
    J Immunol; 1998 Sep; 161(5):2375-82. PubMed ID: 9725233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacterial and retroviral superantigens share a common binding region on class II MHC antigens.
    Torres BA; Griggs ND; Johnson HM
    Nature; 1993 Jul; 364(6433):152-4. PubMed ID: 8391645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deletion of CD4+ T cells and thymocytes by apoptosis in mouse mammary tumor virus (C4)-infected V beta 2 transgenic mice.
    Wang H; Gill RF; Lichlyter D; Iglesias A; Bluethmann H; Wei WZ
    Eur J Immunol; 1994 Dec; 24(12):2950-6. PubMed ID: 7805721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T cells bearing Vbeta8 are preferentially infected with exogenous mouse mammary tumor virus.
    Upragarin N; Nishimura H; Wajjwalku W; Ando Y; Nagafuchi S; Watanabe T; Yoshikai Y
    J Immunol; 1997 Sep; 159(5):2189-95. PubMed ID: 9278306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.